These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2760468)

  • 1. Optimal conditions for the generation of monoclonal antibodies using primary immunisation of mouse splenocytes in vitro under serum-free conditions.
    De Boer M; Ossendorp FA; Van Duijn G; Ten Voorde GH; Tager JM
    J Immunol Methods; 1989 Jul; 121(2):253-60. PubMed ID: 2760468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of monoclonal antibodies to thyroglobulin by in vitro immunization with a free synthetic peptide.
    de Boer M; Ossendorp FA; Al BJ; Hilgers J; de Vijlder JJ; Tager JM
    Mol Immunol; 1987 Oct; 24(10):1081-6. PubMed ID: 3683404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of murine monoclonal antibodies against human thyroglobulin using an in vitro immunization procedure in serum-free medium.
    Ossendorp FA; De Boer M; Al BJ; Hilgers J; Bruning PF; Tager JM
    J Immunol Methods; 1986 Jul; 91(2):257-64. PubMed ID: 3488350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirements for the generation of memory B cells in vivo and their subsequent activation in vitro for the production of antigen-specific hybridomas.
    De Boer M; Ten Voorde GH; Ossendorp FA; Van Duijn G; Tager JM
    J Immunol Methods; 1988 Oct; 113(1):143-9. PubMed ID: 2459251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
    Halabi G; McCullough KC
    J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro immunization. Effect of growth and differentiation factors on antigen-specific B cell activation and production of monoclonal antibodies to autologous antigens and weak immunogens.
    Borrebaeck CA; Möller SA
    J Immunol; 1986 May; 136(10):3710-5. PubMed ID: 3486221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of T-cell-replacing factor and immunogenic dose for the production of monoclonal antibodies using the in vitro immunization technique.
    Borrebaeck CA
    Mol Immunol; 1984 Oct; 21(10):841-5. PubMed ID: 6334231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro immunization of mouse spleen cells for the production of monoclonal IgG1 antibodies using an antigen-specific T helper cell clone (D.10.G4.1).
    Uthoff S; Böldicke T
    J Immunol Methods; 1993 Dec; 166(2):165-75. PubMed ID: 7507145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of IgG-producing hybridomas by in vitro stimulation of murine spleen cells.
    Takahashi M; Fuller SA; Hurrell JG
    J Immunol Methods; 1987 Feb; 96(2):247-53. PubMed ID: 3492563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of monoclonal antibodies specific for African swine fever virus following in vitro primary immunization of mouse splenocytes in the presence of stimulated T lymphocyte supernatants.
    Federspiel G; McCullough KC; Kihm U
    J Immunol Methods; 1991 Dec; 145(1-2):71-81. PubMed ID: 1765668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro immunization of rat spleen lymphocytes with Forssman glycosphingolipid antigen and the generation of a monoclonal antibody.
    Gathuru JK; Miyoshi I; Naiki M
    J Immunol Methods; 1991 Mar; 137(1):95-102. PubMed ID: 2010622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of antigen-specific B lymphocytes during in vitro immunization using carrier-specific T helper hybridomas.
    Schilizzi BM; Kroesen BJ; The TH; de Leij L
    J Immunol Methods; 1992 Aug; 153(1-2):49-56. PubMed ID: 1387673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence for a primary immune response of murine B-lymphocytes after in vitro immunization of dissociated splenocytes.
    de Boer M; Ossendorp FA; Bruning PF; Tager JM
    Hybridoma; 1987 Jun; 6(3):253-8. PubMed ID: 3298001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid generation of monoclonal antibody-secreting hybridomas against African horse sickness virus by in vitro immunization and the fusion/cloning technique.
    Stäuber N; Kihm U; McCullough KC
    J Immunol Methods; 1993 May; 161(2):157-68. PubMed ID: 8505546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of conditions for in vitro antigenic stimulation of dissociated mouse spleen cells for the production of monoclonal antibodies against peptide hormones.
    Rathjen DA; Underwood PA
    J Immunol Methods; 1985 Apr; 78(2):227-37. PubMed ID: 2985707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of in vitro immunisation, as an adjunct to monoclonal antibody production, may result in the production of hybridomas secreting polyreactive antibodies.
    McMahon MJ; O'Kennedy R
    J Immunol Methods; 2001 Dec; 258(1-2):27-36. PubMed ID: 11684120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of monoclonal antibodies against calmodulin by in vitro immunization of spleen cells.
    Pardue RL; Brady RC; Perry GW; Dedman JR
    J Cell Biol; 1983 Apr; 96(4):1149-54. PubMed ID: 6833395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of hybridomas generated by spleen cells of IL-4- and IL-13-knockout mice.
    Shichkin VP; Spivak NY
    Hybridoma (Larchmt); 2005 Dec; 24(6):291-7. PubMed ID: 16332195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved in vitro immunization procedure for the production of monoclonal antibodies.
    Boss BD
    Methods Enzymol; 1986; 121():27-33. PubMed ID: 3724466
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial purification of lymphoblasts after in vitro immunization increases the yield in Ig-producing hybridomas.
    Erkman L; Soldati G; James RW; Kato AC
    J Immunol Methods; 1987 Apr; 98(1):43-52. PubMed ID: 3031165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.